1-2 of 2
Sergio Cortelazzo
Close
Sort by
Journal Articles

Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial

Clinical Trials & Observations
Simone Ferrero, Daniele Grimaldi, Elena Arrigoni, Mariapia Pironti, Gian Maria Zaccaria, Beatrice Alessandria, Elisa Genuardi, Gabriele De Luca, Marco Ghislieri, Rita Tavarozzi, Alice Di Rocco, Alessandro Re, Vittorio Stefoni, Federica Cavallo, Carola Boccomini, Monica Balzarotti, Vittorio Zilioli, Filipa Moita, Luca Arcaini, Elisa Lucchini, Filippo Ballerini, Andrés J. M. Ferreri, Benedetta Puccini, Giuseppe A. Palumbo, Sara Galimberti, Sergio Cortelazzo, Antonello Di Paolo, Marco Ladetto
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3764–3774.
https://doi.org/10.1182/bloodadvances.2022009504
Published: 2023
Includes: Supplemental data
Journal Articles

Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML

Clinical Trials & Observations
Renato Bassan, Tamara Intermesoli, Arianna Masciulli, Chiara Pavoni, Cristina Boschini, Giacomo Gianfaldoni, Filippo Marmont, Irene Cavattoni, Daniele Mattei, Elisabetta Terruzzi, Lorella De Paoli, Chiara Cattaneo, Erika Borlenghi, Fabio Ciceri, Massimo Bernardi, Anna M. Scattolin, Elisabetta Todisco, Leonardo Campiotti, Paolo Corradini, Agostino Cortelezzi, Dario Ferrero, Pamela Zanghì, Elena Oldani, Orietta Spinelli, Ernesta Audisio, Sergio Cortelazzo, Alberto Bosi, Brunangelo Falini, Enrico M. Pogliani, Alessandro Rambaldi
Journal: Blood Advances
Blood Adv (2019) 3 (7): 1103–1117.
https://doi.org/10.1182/bloodadvances.2018026625
Published: 2019
Includes: Supplemental data